220 related articles for article (PubMed ID: 31758471)
1. Relevant Weight Reduction and Reversed Metabolic Co-morbidities Can Be Achieved by Duodenojejunal Bypass Liner in Adolescents with Morbid Obesity.
Homan M; Kovač J; Orel R; Battelino T; Kotnik P
Obes Surg; 2020 Mar; 30(3):1001-1010. PubMed ID: 31758471
[TBL] [Abstract][Full Text] [Related]
2. Is duodeno-jejunal bypass liner superior to pylorus preserving bariatric surgery in terms of complications and efficacy?
Balint IB; Csaszar F; Somodi K; Ternyik L; Biro A; Kaposztas Z
Langenbecks Arch Surg; 2021 Aug; 406(5):1363-1377. PubMed ID: 33712874
[TBL] [Abstract][Full Text] [Related]
3. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates.
Gersin KS; Rothstein RI; Rosenthal RJ; Stefanidis D; Deal SE; Kuwada TS; Laycock W; Adrales G; Vassiliou M; Szomstein S; Heller S; Joyce AM; Heiss F; Nepomnayshy D
Gastrointest Endosc; 2010 May; 71(6):976-82. PubMed ID: 20304396
[TBL] [Abstract][Full Text] [Related]
4. Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis.
Günthert SJ; Aksan A; Schröder O; Meyer G; Hausmann J; Stein J; Stier C
Surg Endosc; 2022 Aug; 36(8):5979-5985. PubMed ID: 35378626
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of the Duodeno-Jejunal Bypass Liner in Patients With Metabolic Syndrome: A Multicenter Randomized Controlled Trial (ENDOMETAB).
Caiazzo R; Branche J; Raverdy V; Czernichow S; Carette C; Robert M; Disse E; Barthet M; Cariou B; Msika S; Behal H; Denies F; Dervaux B; Duhamel A; Verkindt H; Pattou F
Ann Surg; 2020 Nov; 272(5):696-702. PubMed ID: 32889869
[TBL] [Abstract][Full Text] [Related]
6. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.
Koehestanie P; de Jonge C; Berends FJ; Janssen IM; Bouvy ND; Greve JW
Ann Surg; 2014 Dec; 260(6):984-92. PubMed ID: 25072436
[TBL] [Abstract][Full Text] [Related]
7. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner.
Escalona A; Pimentel F; Sharp A; Becerra P; Slako M; Turiel D; Muñoz R; Bambs C; Guzmán S; Ibáñez L; Gersin K
Ann Surg; 2012 Jun; 255(6):1080-5. PubMed ID: 22534421
[TBL] [Abstract][Full Text] [Related]
8. Trends in BMI, Glycemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL).
Riedel N; Laubner K; Lautenbach A; Schön G; Schlensak M; Stengel R; Eberl T; Dederichs F; Aberle J; Seufert J
Obes Surg; 2018 Aug; 28(8):2187-2196. PubMed ID: 29504053
[TBL] [Abstract][Full Text] [Related]
9. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients.
Muñoz R; Dominguez A; Muñoz F; Muñoz C; Slako M; Turiel D; Pimentel F; Sharp A; Escalona A
Surg Endosc; 2014 Apr; 28(4):1056-62. PubMed ID: 24196558
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J
Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313
[TBL] [Abstract][Full Text] [Related]
11. The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study.
van Rijn S; Betzel B; de Jonge C; van Dijk DPJ; Janssen IM; Berends FJ; Bouvy ND; Greve JWM
Obes Surg; 2018 May; 28(5):1255-1262. PubMed ID: 29110244
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal evaluation of efficacy, safety and nutritional status during one-year treatment with the duodenal-jejunal bypass liner.
Riedel N; Laubner K; Lautenbach A; Schön G; Schlensak M; Stengel R; Eberl T; Dederichs F; Aberle J; Seufert J
Surg Obes Relat Dis; 2018 Jun; 14(6):769-779. PubMed ID: 29650340
[TBL] [Abstract][Full Text] [Related]
13. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients.
Forner PM; Ramacciotti T; Farey JE; Lord RV
Obes Surg; 2017 Dec; 27(12):3306-3313. PubMed ID: 29018990
[TBL] [Abstract][Full Text] [Related]
14. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
[TBL] [Abstract][Full Text] [Related]
15. Is reimplantation of the duodenal-jejunal bypass liner feasible?
Koehestanie P; Betzel B; Aarts EO; Janssen IM; Wahab P; Berends FJ
Surg Obes Relat Dis; 2015; 11(5):1099-104. PubMed ID: 25979208
[TBL] [Abstract][Full Text] [Related]
16. Sustained weight loss after duodenal-jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m
Boonchaya-Anant P; Bueter M; Gubler C; Gerber PA
Clin Obes; 2023 Feb; 13(1):e12561. PubMed ID: 36239531
[TBL] [Abstract][Full Text] [Related]
17. The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids.
Glaysher MA; Ward J; Aldhwayan M; Ruban A; Prechtl CG; Fisk HL; Chhina N; Al-Najim W; Smith C; Klimowska-Nassar N; Johnson N; Falaschetti E; Goldstone AP; Miras AD; Byrne JP; Calder PC; Teare JP
Clin Nutr; 2021 Apr; 40(4):2343-2354. PubMed ID: 33131909
[TBL] [Abstract][Full Text] [Related]
18. Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes.
Colás A; Varela M; Mraz M; Novak D; Cuesta-Frau D; Vigil L; Benes M; Pelikanova T; Haluzik M; Burda V; Vargas B
Diabetes Metab Res Rev; 2020 May; 36(4):e3287. PubMed ID: 31916665
[TBL] [Abstract][Full Text] [Related]
19. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.
Jirapinyo P; Haas AV; Thompson CC
Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of the endoscopic duodenal-jejunal bypass liner prototype in severe or morbidly obese subjects implanted for up to 3 years.
Quezada N; Muñoz R; Morelli C; Turiel D; Hernández J; Pimentel F; Escalona A
Surg Endosc; 2018 Jan; 32(1):260-267. PubMed ID: 28664427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
